Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Thrombosis
- Focus Pharmacokinetics
- 09 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.
- 26 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 04 May 2012 New trial record